鑑定及びカウンセリングによりIP資産を評価する
弊所は、一特許に関する一鑑定から、複雑な特許ポートフォリオ又は訴訟に関する長期間にわたるカウンセリングまで、年間数百に上る鑑定を手掛けています。弊所は、日ごろから、特許の有効性、行使可能性、営業の自由(FTO)、特許権濫用、侵害回避問題、ライセンスの可能性、知的財産契約の構築や執行、及び輸出規制を手掛けています。弊所は、クライアント企業の法務、ビジネス、及び技術部門のスタッフと連携して、アイデアから収益を生み出すポートフォリオに関わる潜在的リスクや利益の特定に取り組んでいます。
特許取引のカウンセリングに加え、訴訟前戦略に関する助言も日常的に行っています。幅広い訴訟経験から弊所が得た見識をもって、相手方が提起しうる様々なタイプの議論に取り組みます。弊所の訴訟及びIP取引に関する経験を活かし、訴訟前や訴訟中にクライアント企業に有利な紛争和解へと導くことが可能です。
Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.
Finnegan is lead and preferred IP strategy counsel for one of the largest pharmaceutical companies in the world, handling all aspects of prosecution and portfolio management for multiple top-tier products for the client. The work spans the gamut from drafting and prosecution through larger strategic planning, patent term extension, and pre-litigation preparation on blockbuster small molecule and biologic products in the oncology, rheumatology, immunology, neuromuscular, and cell and gene therapy spaces.
Finnegan represents Huddly AS, a leading developer of advanced camera systems for team collaboration, in patent prosecution and counseling matters. The firm works closely with Huddly to shape a comprehensive patent strategy that protects its portfolio of videoconferencing technologies, which integrate design, hardware, software, and artificial intelligence (AI) to deliver intelligent, high-performance imaging solutions.
Finnegan represents BrainCo, a developer of brain-machine interface (BMI) wearables that combine electroencephalography (EEG) signal processing with artificial intelligence (AI) and machine learning (ML) to enable users to control electronic devices using brain signals. The firm works with BrainCo to develop and implement its intellectual property strategy, including drafting and prosecuting utility and design patent applications, in support of the company’s efforts to build a robust patent portfolio covering innovations and designs related to BMI technologies used in toys, smart home appliances, and robotic devices.
Federal Circuit IP Blog
April 15, 2026
Federal Circuit IP Blog
Federal Circuit Reverses Indefiniteness Ruling on Means-Plus-Function Claim
April 15, 2026
Webinar
January 11, 2024
Webinar
Commentary
How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success
December 16, 2020
Charles T. Collins-Chase
Esther H. Lim Nominated as Candidate for President-Elect of the D.C. Bar
March 6, 2017
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.